By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –The Scripps Translational Science Institute (STSI) and partner Sangamo BioSciences will use a $7.9 million grant from the National Institutes of Health to fund a multidisciplinary study of a region of the human genome thought to be involved in heart disease.

STSI and Sangamo will partner to use induced pluripotent stem (IPS) cells and zinc finger nuclease (ZFN)-based genetic editing in a "disease-in-a-dish" study of the 9p21 region of the genome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.